glp-1 and type 2 diabetes Receptor Agonists as Treatments for GLP-1 Impact: How GLP-1s Are

Addressing underlying conditions: Treatment should target identified respiratory or cardiovascular conditions

If such were to happen, the door to expand access to coverage remains possible in the future

Seek urgent medical attention if night sweats occur with: Drenching sweats with high fever Chest pain or severe shortness of breath Confusion or disorientation Severe symptoms in immunocompromised individuals Contact your healthcare provider if night sweats occur with: Unexplained weight loss (beyond expected weight loss from GLP-1 therapy) Persistent fever or chills Fatigue that interferes with daily activities Enlarged lymph nodes Persistent cough Changes in bowel habits or blood in stool (if other concerning symptoms are present) For patients with diabetes, symptoms suggesting hypoglycemia during sleep episodes require prompt evaluation

Blood glucose lowering and glucagonostatic effects of glucagon-like peptide I in insulin-deprived diabetic dogs

Jama 331 , 3848 (2024)

$307 billion is spent annually on direct medical costs